GoRden K B，GoRski K S，Gibson S J，et al． Synthetic TLR agonists Reveal functional diffeRences between human TLR7 and TLR8[J]． J Immunol，2005，174 ( 3) : 1259 - 1268．
[9]
Santiago-RabeR M L，Dunand-SauthieR I，Wu T，et al． CRitical Role of TLR7 in the acceleRation of systemic lupus eRythematosus in TLR9-deficient mice[J]． J Autoimmun， 2010， 34( 4) : 339 - 348．
Lund J M，Alxopoulou L，Sato A， et al． Recognition of single- stRanded RNA viRus by toll-like ReceptoR 7[J]． PRoc Natl Acad Sci USA， 2004， 101( 15) : 5598 - 5603．
[12]
Antos B P，ValveRde J V，RohR P， et al． TLR7 /8 /9 polymoRphisms and theiR associations in systemic lupus eRythematosus patients fRom SoutheRn BRazil [J]． Lupus， 2012， 21( 3) : 302 - 309．
[13]
Nian H，Geng W Q，Cui H L， et al． R-848 tRiggeRs the expRession of TLR7 /8 and suppResses HIV Replication in monocytes[J]． BMC Infect Dis， 2012， 12( 5) : 1 - 11．
[14]
MeieR A，AlteR G，FRahm N， et al． MyD88-Dependent Immune Activation Mediated by Human Immunodeficiency ViRus Type 1-Encoded Toll-Like ReceptoR Ligands [J]． J ViRol， 2007， 81( 15) : 8180 - 8191．
